Table 5. Univariate analysis of risk factors for the infection of MDROs.
| Exposure factor | MDROs Group (n = 71) | NMDRO Group (n = 83) | OR-value | 95% CI | P-value | ||
|---|---|---|---|---|---|---|---|
| + | − | + | − | ||||
| Previous antimicrobial exposure | 63 | 8 | 35 | 41 | 8.944 | (2.349,34.049) | 0.001 |
| Combined osteomyelitis | 51 | 20 | 14 | 62 | 4.140 | (1.219,14.064) | 0.023 |
| Concomitant neuropathy | 60 | 11 | 55 | 21 | 0.297 | (0.078,1.122) | 0.073 |
| Concomitant retinopathy | 20 | 51 | 21 | 55 | 2.141 | (0.612,7.484) | 0.233 |
| Complicated nephropathy | 32 | 41 | 31 | 45 | 0.468 | (0.135,1.623) | 0.232 |
| The same infected wound >2 times per year | 19 | 52 | 18 | 58 | 0,143 | (0.030,0.682) | 0.015 |
| Whether to amputate toe/limb | 16 | 55 | 10 | 66 | 2.746 | (0.642,11.744) | 0.173 |
| Wanger grade 3–5 | 50 | 21 | 27 | 49 | 0.157 | (0.030,0.808) | 0.027 |
| Ischemic nerve wound | 48 | 23 | 25 | 51 | 36.790 | (8.386,161.395) | 0.000 |